3Mrozek E, Povoski SP, Shapiro CL. The challenges of individ- ualized care for older patients with localized breast cancer [ J]. Expert Rev Anticancer Ther,2013,13 ( 8 ) :963 - 973.
4Johannsen M, Farver I, Beck N, et al. The efficacy of psycho- social intervention for pain in breast cancer patients and sur- vivors : a systematic review and meta - analysis [ J ]. Breast Cancer Res treat ,2013,138 ( 3 ) :675 - 690.
5HERDMAN M, GUDEX C, LLOYD A, et al. Development and preliminary testing of the new five-level version of EQ-5D(EQ-5D-5L)[J]. Quality of life research, 2011,20(10): 1727-1236.
6JANSSEN M F, BIRNIE E, BONSEL G J. Quantification of the level descriptors for the standard EQ-5D three-level sys-tem and a five-level version according to two methods[J|. Quality of life research, 2008,17(3):463-473.
7AGBORSANGAYA C B, LAHTINEN M, COOKE T, et al. Comparing the EQ-5D 3L and 5L: measurement properties and association with chronic conditions and multimorbidity in the general population[J]. Health and quality of life out-comes, 2014(12):74.
8TRAN B X, OHINMAA A, NGUYEN L T. Quality of life pro-file and psychometric properties of the EQ-5D-5L in HIV/ AIDS patients[J]. Health and quality of life outcomes, 2012 (10): 132.
9LUO N, LI M, LIU G G, et al. Developing the Chinese ver-sion of the new 5-level EQ-5D descriptive system: the re-sponse scaling approach|J]. Quality of life research, 2013,22 (4): 885-890.
10OHADOVIC M, LAL A, LIEDGENS H. Validity and respon-siveness of EuroQol-5 dimensi〇n(EQ-5D) versus Short Form-6 dimension(SF-6D) questionnaire in chronic pain[J]. Health and quality of life outcomes, 2013(11):110.
